Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
Author:
Affiliation:
1. Department of Statistics, The Islamia University, Bahawalpur, Pakistan
2. Department of Mathematics, School of Arts and Science, University of The Gambia, Serekunda, The Gambia
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2160491
Reference40 articles.
1. Center for Systems Science and Engineering at Johns Hopkins University. COVID-19 dashboard; 2022. Available from: https://coronavirus.jhu.edu/map.html
2. Association Between Air Pollutants and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Time Stratified Case‐Crossover Design With a Distributed Lag Nonlinear Model
3. Gender differences in specific trends of COPD mortality in Croatia
4. World Health Organization (WHO). Global tuberculosis report 2022. License: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
5. Gong W Parkkila S Wu X et al. SARS-CoV-2 variants and COVID-19 vaccines: current challenges and future strategies. Int Rev Immunol. 2022:1–22.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevalence of sexually transmitted infections (STIs) among first time visitors at STIs clinic in Hangzhou, China: Assessing the influence of the COVID‐19 pandemic;Immunity, Inflammation and Disease;2024-09
2. Exploring critical factors in referral systems at different health‐care levels;World Medical & Health Policy;2024-08-22
3. Impacts of travel duration on urban-rural resident free vaccination behavior: Chinese COVID-19 vaccine booster dose evidence;Human Vaccines & Immunotherapeutics;2024-06-06
4. Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations;PLOS Neglected Tropical Diseases;2024-05-13
5. Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review;Immunity, Inflammation and Disease;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3